GSTP1 and neoplasm: Drug resistance observed in tumor tissues have been associated with the overexpression of GSTP1, which effectively blocks JNK signaling pathways (Adler et al., 1999) while specific inhibitors of GSTP1 induce activation of JNK (Burg et al., 2006).